Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

Clinical trial NCT04114188 · COMPLETED

Trial details

NCT number: NCT04114188
Sponsor: Prof. Dr. Petra Reinke
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Transplant Rejection

Start date: 2016-12-15
Primary completion: 2020-12-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.